All

Epidemiology of Renal Cell Carcinoma

Posted on by SGW Content
11
Feb
Umberto Capitanio 1, Karim Bensalah 2, Axel Bex 3, Stephen A Boorjian 4, Freddie Bray 5, Jonathan Coleman 6, John L Gore 7, Maxine Sun 8, Christopher Wood 9, Paul Russo 10
Affiliations Expand
PMID: 30243799
PMCID: PMC8397918
DOI: 10.1016/j.eururo.2018.08.036

Abstract

Context: Despite the improvement in renal cell carcinoma (RCC) diagnosis and management observed during the last 2 decades, RCC remains one of the most lethal urological malignancies. With the expansion of routine imaging for many disorders, an increasing number of patients who harbour RCC are identified incidentally.

Objective: To summarise and compare RCC incidence and mortality rates, analyse the magnitude of risk factors, and interpret these epidemiological observations in the context of screening and disease management.

Evidence acquisition: The primary objective of the current review was to retrieve and describe worldwide RCC incidence/mortality rates. Secondly, a narrative literature review about the magnitude of the known risk factors was performed. Finally, data retrieved from the first two steps were elaborated to define the clinical implications for RCC screening.

Evidence synthesis: RCC incidence and mortality significantly differ among individual countries and world regions. Potential RCC risk factors include behavioural and environmental factors, comorbidities, and analgesics. Smoking, obesity, hypertension, and chronic kidney disease represent established risk factors. Other factors have been associated with an increased RCC risk, although selection biases may be present and controversial results have been reported.

Conclusions: Incidence of RCC varies worldwide. Within the several RCC risk factors identified, smoking, obesity, and hypertension are most strongly associated with RCC. In individuals at a higher risk of RCC, the cost effectiveness of a screening programme needs to be assessed on a country-specific level due to geographic heterogeneity in incidence and mortality rates, costs, and management implications. Owing to the low rates of RCC, implementation of accurate biomarkers appears to be mandatory.

Patient summary: The probability of harbouring kidney cancer is higher in developed countries and among smokers, obese individuals, and individuals with hypertension.

Keywords: Epidemiology; Incidence; Kidney cancer; Mortality; Prevalence; Renal cancer.

PubMed Disclaimer

Figures

Fig. 1 –

Fig. 2 –

Fig. 3 –

Fig. 4 –

Comment in

Similar articles

See all similar articles

Cited by

See all “Cited by” articles

References

    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin 2018;68:7–30. – PubMed
    1. Capitanio U, Montorsi F. Renal cancer. Lancet 2016;387:894–906. – PubMed
    1. Ferlay J, Soerjomataram I, Ervik M, et al.GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 11. Lyon, France: International Agency for Research on Cancer; 2013. http://globocan.iarc.fr.
    1. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al.Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013;49:1374–403. – PubMed
    1. http://www.cancerresearchuk.org/health-professional/cancer-statistics/st….
    1. Levi F, Ferlay J, Galeone C, et al.The changing pattern of kidney cancer incidence and mortality in Europe. BJU Int 2008;101:949–58. – PubMed
    1. King SC, Pollack LA, Li J, King JB, Master VA. Continued increase in incidence of renal cell carcinoma, especially in young patients and high grade disease: United States 2001 to 2010. J Urol 2014;191:1665–70. – PMC – PubMed
    1. Bergström A, Hsieh CC, Lindblad P, Lu CM, Cook NR, Wolk A. Obesity and renal cell cancer—a quantitative review. Br J Cancer 2001;85:984–90. – PMC – PubMed
    1. Yang X-F, Ma G, Feng N-H, Yu D-S, Wu Y, Li C. Twist2 and CD24 expression alters renal microenvironment in obesity associated kidney cancer. Eur Rev Med Pharmacol Sci 2018;22:358–64. – PubMed
    1. Macleod LC, Hotaling JM, Wright JL, et al.Risk factors for renal cell carcinoma in the VITAL study. J Urol 2013;190:1657–61. – PMC – PubMed
    1. Liao LM, Hofmann JN, Cho E, Pollak MN, Chow W-H, Purdue MP. Circulating levels of obesity-related markers and risk of renal cell carcinoma in the PLCO cancer screening trial. Cancer Causes Control 2017;28:801–7. – PMC – PubMed
    1. Gild P, Ehdaie B, Kluth LA. Effect of obesity on bladder cancer and renal cell carcinoma incidence and survival. Curr Opin Urol 2017;27:409–14. – PubMed
    1. Lotan Y, Karam JA, Shariat SF, et al.Renal-cell carcinoma risk estimates based on participants in the prostate, lung, colorectal, and ovarian cancer screening trial and national lung screening trial. Urol Oncol 2016;34, 167.e9–16. – PubMed
    1. Zhang X-L, Liu M, Qian J, et al.Statin use and risk of kidney cancer: a meta-analysis of observational studies and randomized trials. Br J Clin Pharmacol 2014;77:458–65. – PMC – PubMed
    1. Behrens G, Leitzmann MF. The association between physical activity and renal cancer: systematic review and meta-analysis. Br J Cancer 2013;108:798–811. – PMC – PubMed
    1. Zhao J, Zhao L. Cruciferous vegetables intake is associated with lower risk of renal cell carcinoma: evidence from a meta-analysis of observational studies. PLoS One 2013;8:e75732. – PMC – PubMed
    1. Liu B, Mao Q, Wang X, et al.Cruciferous vegetables consumption and risk of renal cell carcinoma: a meta-analysis. Nutr Cancer 2013;65:668–76. – PubMed
    1. Weikert S, Boeing H, Pischon T, et al.Fruits and vegetables and renal cell carcinoma: findings from the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer 2006;118:3133–9. – PubMed
    1. Jay R, Brennan P, Brenner DR, et al.Alcohol consumption and the risk of renal cancers in the European Prospective Investigation into Cancer and Nutrition (EPIC). Wozniak MB, Brennan P, Brenner DR, Overvad K, Olsen A, Tjønneland A, Boutron-Ruault MC, Clavel-Chapelon F, Fagherazzi G, Katzke V, Kühn T, Boeing H, Bergmann MM, Steffen A, Naska A, Trichopoulou A, Trichopoulos D, Saieva C, Grioni S, Panico S, Tumino R, Vineis P, Bueno-de-Mesquita HB, Peeters PH, Hjartåker A, Weiderpass E, Arriola L, Molina-Montes E, Duell EJ, Santiuste C, Alonso de la Torre R, Barricarte Gurrea A, Stocks T, Johansson M, Ljungberg B, Wareham N, Khaw KT, Travis RC, Cross AJ, Murphy N, Riboli E, Scelo G. Int J Cancer. 2015October15;137 (8):1953–66. [Epub 2015 Apr 28]. doi: 10.1002/ijc.29559. Urol Oncol 2017;35(3):117. – DOI – PubMed
    1. Lew JQ, Chow W-H, Hollenbeck AR, Schatzkin A, Park Y. Alcohol consumption and risk of renal cell cancer: the NIH-AARP diet and health study. Br J Cancer 2011;104:537–41. 10.1038/sj.bjc.6606089. – DOI – PMC – PubMed
    1. Pelucchi C, Galeone C, Montella M, et al.Alcohol consumption and renal cell cancer risk in two Italian case-control studies. Ann Oncol 2008;19:1003–8. – PubMed
    1. Karami S, Daugherty SE, Purdue MP. A prospective study of alcohol consumption and renal cell carcinoma risk. Int J Cancer 2015;137:238–42. – PMC – PubMed
    1. Xu X, Zhu Y, Zheng X, Xie L. Does beer, wine or liquor consumption correlate with the risk of renal cell carcinoma? A dose-response meta-analysis of prospective cohort studies. Oncotarget 2015;6:13347–58. – PMC – PubMed
    1. Cumberbatch MG, Rota M, Catto JWF, La Vecchia C. The role of tobacco smoke in bladder and kidney carcinogenesis: a comparison of exposures and meta-analysis of incidence and mortality risks. Eur Urol 2016;70:458–66. – PubMed
    1. Chien C-C, Han M-M, Chiu Y-H, et al.Epidemiology of cancer in end-stage renal disease dialysis patients: a national cohort study in Taiwan. J Cancer 2017;8:9–18. – PMC – PubMed
    1. Mazzucotelli V, Piselli P, Verdirosi D, et al.De novo cancer in patients on dialysis and after renal transplantation: north-western Italy, 1997–2012. J Nephrol 2017;30:851–7. – PubMed
    1. Hidayat K, Du X, Zou S-Y, Shi B-M. Blood pressure and kidney cancer risk. J Hypertens 2017;35:1333–44. – PubMed
    1. Sharifi N, Farrar WL. Perturbations in hypoxia detection: a shared link between hereditary and sporadic tumor formation? Med Hypotheses 2006;66:732–5. 10.1016/j.mehy.11.2005.003. – DOI – PubMed
    1. Gago-Dominguez M, Castelao JE, Yuan J-M, Ross RK, Yu MC. Lipid peroxidation: a novel and unifying concept of the etiology of renal cell carcinoma (United States). Cancer Causes Control 2002;13:287–93. – PubMed
    1. Cheungpasitporn W, Thongprayoon C, O’Corragain OA, et al.The risk of kidney cancer in patients with kidney stones: a systematic review and meta-analysis. QJM 2015;108:205–12. – PubMed
    1. Hendriks SH, Schrijnders D, van Hateren KJ, et al.Association between body mass index and obesity-related cancer risk in men and women with type 2 diabetes in primary care in the Netherlands: a cohort study (ZODIAC-56). BMJ Open 2018;8:e018859. – PMC – PubMed
    1. Pearson-Stuttard J, Zhou B, Kontis V, Bentham J, Gunter MJ, Ezzati M. Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment. Lancet Diabetes Endocrinol 2018;6:e6–15. – PMC – PubMed
    1. Joh H-K, Willett WC, Cho E. Type 2 diabetes and the risk of renal cell cancer in women. Diabetes Care 2011;34:1552–6. – PMC – PubMed
    1. Christensson A, Savage C, Sjoberg DD, et al.Association of cancer with moderately impaired renal function at baseline in a large, representative, population-based cohort followed for up to 30 years. Int J Cancer 2013;133:1452–8. – PMC – PubMed
    1. Lowrance WT, Ordoñez J, Udaltsova N, Russo P, Go AS. CKD and the risk of incident cancer. J Am Soc Nephrol 2014;25:2327–34. – PMC – PubMed
    1. Gonzalez HC, Lamerato L, Rogers CG, Gordon SC. Chronic hepatitis C infection as a risk factor for renal cell carcinoma. Dig Dis Sci 2015;60:1820–4. 10.1007/s10620-015-3521-3. – DOI – PubMed
    1. Lambe M, Lindblad P, Wuu J, Remler R, Hsieh CC. Pregnancy and risk of renal cell cancer: a population-based study in Sweden. Br J Cancer 2002;86:1425–9. – PMC – PubMed
    1. Kabat GC, Silvera SAN, Miller AB, Rohan TE. A cohort study of reproductive and hormonal factors and renal cell cancer risk in women. Br J Cancer 2007;96:845–9. – PMC – PubMed
    1. Molokwu JC, Prizment AE, Folsom AR. Reproductive characteristics and risk of kidney cancer: Iowa Women’s Health Study. Maturitas 2007;58:156–63. – PubMed
    1. Lee JE, Hankinson SE, Cho E. Reproductive factors and risk of renal cell cancer: the Nurses’ Health Study. Am J Epidemiol 2009;169:1243–50. – PMC – PubMed
    1. Chow W-H, Dong LM, Devesa SS. Epidemiology and risk factors for kidney cancer. Nat Rev Urol 2010;7:245–57. – PMC – PubMed
    1. Cho E, Curhan G, Hankinson SE, et al.Prospective evaluation of analgesic use and risk of renal cell cancer. Arch Intern Med 2011;171:1487–93. – PMC – PubMed
    1. Choueiri TK, Je Y, Cho E. Analgesic use and the risk of kidney cancer: a meta-analysis of epidemiologic studies. Int J Cancer 2014;134:384–96. – PMC – PubMed
    1. Desimone MC, Rathmell WK, Threadgill DW. Pleiotropic effects of the trichloroethylene-associated P81S VHL mutation on metabolism, apoptosis, and ATM-mediated DNA damage response. J Natl Cancer Inst 2013;105:1355–64. – PMC – PubMed
    1. Moore LE, Boffetta P, Karami S, et al.Occupational trichloroethylene exposure and renal carcinoma risk: evidence of genetic susceptibility by reductive metabolism gene variants. Cancer Res 2010;70:6527–36. – PMC – PubMed
    1. Abdul KSM, Jayasinghe SS, Chandana EPS, Jayasumana C, De Silva PMCS. Arsenic and human health effects: a review. Environ Toxicol Pharmacol 2015;40:828–46. – PubMed
    1. Song JK, Luo H, Yin XH, et al.Association between cadmium exposure and renal cancer risk: a meta-analysis of observational studies. Sci Rep 2015;5:17976. – PMC – PubMed
    1. Di Trapani E, Dell’Oglio P, Larcher A, et al.Pathological high-risk renal cell carcinoma: trends in clinical characteristics over 25 years. Anticancer Res 2018;38:4123–30. – PubMed
    1. Rouprêt M. Smoking status is not sufficient to accurately target patients who would benefit from screening for bladder and kidney cancer. Eur Urol Focus 2015;1:52–3. – PubMed
    1. Pinsky PF, Dunn B, Gierada D, et al.Incidental renal tumours on low-dose CT lung cancer screening exams. J Med Screen 2017;24:104–9. – PubMed
    1. Welch HG, Skinner JS, Schroeck FR, Zhou W, Black WC. Regional variation of computed tomographic imaging in the United States and the risk of nephrectomy. JAMA Intern Med 2018;178:221–7. – PMC – PubMed
    1. Rossi SH, Klatte T, Usher-Smith J, Stewart GD. Epidemiology and screening for renal cancer. World J Urol 2018;36:1341–53. – PMC – PubMed
    1. Morrissey JJ, Mobley J, Figenshau RS, Vetter J, Bhayani S, Kharasch ED. Urine aquaporin 1 and perilipin 2 differentiate renal carcinomas from other imaged renal masses and bladder and prostate cancer. Mayo Clin Proc 2015;90:35–42. – PMC – PubMed
SGW Content

Leave a Reply

Your email address will not be published. Required fields are marked *